Podcast: Regulus Therapeutics and microRNA Drug Delivery - - BioPharm International

ADVERTISEMENT

Podcast: Regulus Therapeutics and microRNA Drug Delivery


blog comments powered by Disqus


BioPharm International interviews Bal Bhat, senior director and head of chemistry at Regulus, whose core technology focuses on microRNA drug delivery. Bhat addresses some of the challenges of using microRNA therapeutically and explains Regulus’ conscious decision to use single-stranded microRNA. The possibility of targeting specific tissues using a local delivery system or a packaging molecule is also discussed. Finally, Bhat describes the reactions of potential pharma partners to Regulus’ research data and how the project will move forward.

Related article on Perspectives in MicroRNA Therapeutics

ADVERTISEMENT

ADVERTISEMENT

Baxter Initiates Voluntary Recall of Potassium Chloride Injection
September 17, 2014
PDA Announces Technical Report on Drug Shortages
September 9, 2014
European Commission Approves RoACTEMRA for Treatment of RA
September 9, 2014
FDA Releases Guidance Electronic Submission of Lot Distribution Reports
September 5, 2014
Infinity and AbbVie Collaborate to Develop Oncology Drug
September 5, 2014
Author Guidelines

Click here